Viriom
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
12760 High Bluff Dr Ste 370, San Diego, ...Phone Number
(858) 794-4860Website
www.viriom.comRevenue
$17.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Viriom
Viriom Inc. is dedicated to advancing a pipeline of effective and affordable treatments for globally significant diseases, focusing on both infectious and malignant conditions. The company targets blood-borne and respiratory viral diseases, as well as solid tumors in oncology. With a strong network of partners, Viriom aims to build a global drug development platform that enhances access to innovative therapies for both developed and developing countries. Their mission is to ensure that effective treatments are accessible to all individuals, regardless of their location.Explore more
Viriom Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viriom your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Viriom has recently received funding, and reach out quickly before it becomes old news!
Check out if Viriom is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Viriom recently announced quarterly report
Viriom, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Viriom had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Viriom has new funding data
Congratulate Masked Content for being promoted to Masked Content at Viriom
Product Launch: Get notified when Viriom launches new products
Recommended Actions
Reach out to Masked Content who joined Viriom as Masked Content
Find more new buyers
Compare Similar Companies to Viriom
Compare insights from companies similar to Viriom, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Viriom is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Viriom is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Viriom.
Viriom financials insights
Gather financial insights about Viriom, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$2.4M
Other Financing Round
$4.7M
Viriom Tech Stack
A closer look at the technologies used by Viriom
Viriom News & Media
Viriom's Single Pill Influenza Treatment Completes Critical Phase I Clinical Trials
SAN DIEGO, Nov. 20, 2023 /PRNewswire/ -- Viriom Inc., dedicated to advancing a pipeline of highly effective and broadly affordable treatments targeting infectious and malignant diseases globally, announces the successful completion and positive results of Phase I clinical trial for...Viriom and Chromis publish results of a multi-center open label post-marketing clinical study in 940 COVID-19 patients confirming efficacy of Avifavir at CROI2021
SAN DIEGO, March 9, 2021 /PRNewswire/ -- Viriom Inc., a San Diego CA-based biotech and Chromis, a joint venture of the ChemRar Group and the Russian Direct Investment Fund (RDIF) reported a summary of the multicenter, open-labeled, efficacy and safety study of Avifavir (favipiravir) in...Elpida (elsulfavirine) becomes the preferred first line therapy for treatment of HIV infection in Russia
SAN DIEGO, Feb. 2, 2021 /PRNewswire/ -- Viriom Inc (Viriom) announces that its antiviral drug Elpida®(elsulfavirine) has been included in the preferred first-line antiretroviral therapy (ART) regimens by the Ministry of Health of the Russian Federation according to updated clinical...Viriom Announces Initiation of Phase 2 Study Investigating Efficacy of Intramuscular Long-Acting Injectable Nanoformulation of VM1500A in HIV-Infected Patients
SAN DIEGO, May 4, 2020 /PRNewswire/ -- Viriom Inc (Viriom) announced today the initiation of a Phase 2a study investigating the efficacy of an intramuscular long-acting injectable nanoformulation of VM1500A in HIV-infected patients. The earlier findings of a Phase 1 study investigating...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viriom
Sign Up For FreeTo access detailed company insights
Viriom Inc. is dedicated to advancing a pipeline of effective and affordable treatments for globally significant diseases, focusing on both infectious and malignant conditions. The company targets blood-borne and respiratory viral diseases, as well as solid tumors in oncology. With a strong network of partners, Viriom aims to build a global drug de... Read More
